Valuation: genOway

Market Cap 2.18Cr 2.48Cr 2.06Cr 1.87Cr 3.51Cr 237.67Cr 3.53Cr 25Cr 9.53Cr 121.42Cr 9.31Cr 9.11Cr 390.23Cr P/E 2024 *
-
P/E 2025 -
Enterprise Value 2.85Cr 3.25Cr 2.69Cr 2.45Cr 4.59Cr 311.05Cr 4.62Cr 32Cr 12Cr 158.91Cr 12Cr 12Cr 510.71Cr EV / Sales 2024
1.36x
EV / Sales 2025 1.22x
Free-Float
59.02%
Yield 2024 *
-
Yield 2025 -
1 day-1.67%
1 week-4.84%
Current month-4.84%
1 month-4.07%
3 months+2.16%
6 months-2.88%
Current year-12.92%
1 week 2.31
Extreme 2.31
2.5
1 month 2.31
Extreme 2.31
2.53
Current year 2.18
Extreme 2.18
2.79
1 year 2.1
Extreme 2.1
3.07
3 years 2.1
Extreme 2.1
4.91
5 years 2.1
Extreme 2.1
4.91
10 years 1
Extreme 1
7.7
Manager TitleAgeSince
Chief Executive Officer - -
Chief Operating Officer - 01/03/1999
Director of Finance/CFO - 01/10/2015
Director TitleAgeSince
Director/Board Member - 01/03/1999
Chairman - -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap. Importance
20/01/22 Buy

Chief Executive Officer

12,500 0.1376%
17/11/21 Sell

Chief Executive Officer

5,000 0.0553%
13/11/21 Sell

Founder

1,147 0.0127%
Change 5-day change 1-year change 3-year change Capi.($)
-1.67%-4.84%-20.81%-44.47% 2.48Cr
-0.14%+4.33%+9.00%+34.85% 4.8TCr
-1.69%+1.48%+50.57%+33.71% 4.45TCr
+2.56%+7.34%+366.69%+609.24% 4.39TCr
+0.24%+2.85%+10.67%+87.77% 4.1TCr
-0.62%-1.11%+4.65%+46.13% 2.99TCr
-0.28%+1.07%+24.58%+149.55% 1.73TCr
+3.37%+9.21%+8.32% - 1.53TCr
-0.46%+1.20%+26.90%+43.26% 1.53TCr
-2.21%-4.70% - - 1.48TCr
Average -0.09%+1.63%+53.40%+120.00% 2.7TCr
Weighted average by Cap. +0.11%+2.86%+79.66%+159.07%

Financials

2024 2025
Net sales 2.58Cr 2.95Cr 2.44Cr 2.22Cr 4.16Cr 282.27Cr 4.19Cr 29Cr 11Cr 144.2Cr 11Cr 11Cr 463.46Cr 2.6Cr 2.97Cr 2.46Cr 2.24Cr 4.19Cr 284.31Cr 4.22Cr 29Cr 11Cr 145.25Cr 11Cr 11Cr 466.81Cr
Net income 18.31L 20.86L 17.29L 15.76L 29.5L 20Cr 29.71L 2.07Cr 80.14L 10Cr 78.33L 76.64L 33Cr 9L 10.57L 9L 8L 14.95L 10Cr 15.05L 1.05Cr 40.61L 5.18Cr 39.7L 38.84L 17Cr
Net Debt 6L 7L 6L 5L 10.04L 6.8Cr 10.11L 70.41L 27.27L 3.48Cr 26.66L 26.08L 11Cr 67.18L 76.56L 63.45L 57.82L 1.08Cr 73Cr 1.09Cr 7.59Cr 2.94Cr 37Cr 2.87Cr 2.81Cr 120.48Cr
Logo genOway
genOway est une société de biotechnologie spécialisée dans la conception et le développement de modèles de recherche moléculaires, cellulaires et animaux à forte valeur ajoutée pour les industries biopharmaceutique, chimique, agrochimique et agroalimentaire ainsi que pour la recherche académique. genOway est une société leader sur son marché. Elle appuie son développement sur la combinaison d'une large et exclusive plateforme technologique et d'une propriété intellectuelle forte combinant brevets et licences d'exploitation. genOway a conclu de nombreux contrats commerciaux avec les leaders de l'industrie pharmaceutique (BMS, Janssen, Novartis, Pfizer, etc.), et avec les centres de recherche académiques les plus prestigieux (King's College et Université de Manchester en Angleterre, Harvard, Caltech et le National Institute of Health aux Etats-Unis, l'Institut Pasteur en France, le NGFN et l'Institut Max Planck en Allemagne, etc.).
Employees
157
Date Price Change Volume
25/26/25 €2.360 -1.67% 4,887
24/26/24 €2.400 0.00% 58,604
23/26/23 €2.400 -1.64% 5,522
22/26/22 €2.440 -1.61% 4,883
21/26/21 €2.480 0.00% 2,810
  1. Stock Market
  2. Stocks
  3. ALGEN Stock